Genetic polymorphisms of steroid hormone metabolizing enzymes are associated with severity of liver disease and risk of hepatocellular carcinoma in hepatitis C infected patients
Rossi, L.N.; Leveri, M.; Gritti, C.; De Silvestri, A.; Zavaglia, C.; Civardi, E.; Mondelli, M.; Silini, E.M.
International Journal of Cancer Suppl (13): 112
2002
ISSN/ISBN: 0020-7136
Accession: 034984937
PDF emailed within 1 workday: $29.90
Related References
Rossi, L.; Leveri, M.; Gritti, C.; De Silvestri, A.; Zavaglia, C.; Sonzogni, L.; Silvestri, L.; Civardi, E.; Mondelli, M.U.; Silini, E.M. 2003: Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients Journal of Hepatology 39(4): 564-570Rossi, L.; Leveri, M.; Gritti, C.; De Silvestri, A.; Zavaglia, C.; Civardi, E.; Mondelli, M.U.; Silini, E.M. 2003: Genetic polymorphisms of steroid hormone metabolising enzymes and risk of liver disease progression and cancer in hepatitis C infected patients Journal of Hepatology 38(Suppl 2): 17
Ceni, E.; Galli, A.; Surrenti, C.; Casini, A. 1997: Genetic polymorphisms in ethanol metabolizing enzymes do not influence the severity of alcoholic liver disease in Italian patients Hepatology 26(4 Part 2): 273A
Munaka, M.; Kohshi, K.; Kawamoto, T.; Takasawa, S.; Nagata, N.; Itoh, H.; Oda, S.; Katoh, T. 2003: Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma Journal of Cancer Research and Clinical Oncology 129(6): 355-360
Borentain, P.; Gerolami, V.; Ananian, P.; Garcia, S.; Noundou, A.; Bottafridlund, D.; Patrice le Treut, Y.; Bergelefranc, J.L.; Gerolami, R. 2007: DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients European Journal of Cancer (1990) 43(17): 2479-2486
Borentain, P.; Gérolami, V.; Ananian, P.; Garcia, S.ép.; Noundou, A.; Botta-Fridlund, D.; Le Treut, Y.P.; Bergé-Lefranc, J.L.; Gérolami, R.é 2007: DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients European Journal of Cancer 43(17): 2479-2486
Paik, N.; Sinn, D.H.; Lee, J.H.; Oh, I.S.; Kim, J.H.; Kang, W.; Gwak, G.-Y.; Paik, Y.-H.; Choi, M.S.; Lee, J.H.; Koh, K.C.; Paik, S.W. 2018: Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia Liver International: Official Journal of the International Association for the Study of the Liver 38(1): 68-75
Abd El-Ghaffar, H Abd El-Rahman; Ahmed, A Ismail; Abdelaal, A Abdou; Emam, R Fouad; Mansour, L Ali 2015: Antioxidant enzymes gene polymorphisms and hepatocellular carcinoma in hepatitis C virus-infected Egyptian patients Comparative Clinical Pathology 24(3): 609-615
Haas, S.; Merkelbach-Bruse, S.; Justenhoven, C.; Brauch, H.; Fischer, H-Peter. 2009: Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver Pathology Research and Practice 205(10): 716-725
Salmon-Ceron, D.; Nahon, P.; Layese, R.; Bourcier, V.ér.; Sogni, P.; Bani-Sadr, F.; Audureau, E.; Merchadou, L.; Dabis, F.ço.; Wittkop, L.; Roudot-Thoraval, F.ço. 2019: Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients with Cirrhosis Are no Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients Hepatology 70(3): 939-954
Kirk, G.D.; Turner, P.C.; Gong, Y.; Lesi, O.A.; Mendy, M.; Goedert, J.J.; Hall, A.J.; Whittle, H.; Hainaut, P.; Montesano, R.; Wild, C.P. 2005: Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 14(2): 373-379
Krasnodębski, M.; Grąt, M.ł; Masior, Łu.; Patkowski, W.; Krawczyk, M. 2015: Differential impact of risk factors for tumor recurrence in hepatitis B and hepatitis C virus-infected patients undergoing liver transplantation for hepatocellular carcinoma Annals of Transplantation 20: 70-75
Blasco, C.; Caballeria, J.; Pares, A.; Lligona, A.; Deulofeu, R.; Lluis, J.; Caballeria, L.; Gual, A.; Rodos, J. 2002: Genetic polymorphisms of alcohol metabolizing enzymes do not influence the development of alcoholic liver disease Journal of Hepatology 36(Suppl 1): 143
Goodgame, B.; Shaheen, N.J.; Galanko, J.; El-Serag, H.B. 2003: The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? American Journal of Gastroenterology 98(11): 2535-2542
O'Brien, T.R.; Morgan, T.R.; Pfeiffer, R.M.; Chung, R.T.; Lok, A.S.; Shiffman, M.L.; Dotrang, M.; Sninsky, J.J.; Bonkovsky, H.L. 2011: Il28B Genetic Attributable Risk In Hepatitis C-Associated Hepatocellular Carcinoma And Decompensated Liver Disease Journal of Hepatology 54: S527-S528